• Our Offering
    • Service
      • Dx HEALTH CHECK
      • CRO
      • CDx
      • CDO
      • CMO
      • CSO
      • KHUB CONSORTIUM
      • DTx
    • Product
      • Dx PRODUCT · PIPELINE
      • Vx PRODUCT · PIPELINE
      • CONSUMER HEALTH
      • Dx&Vx 2023 AWARD IMPACT
  • Our Company
    • About Us
      • GOAL & PROMISE
      • ESG
      • LEADERSHIP
      • MICROBIOME HISTORY
      • COMPANY HISTORY
    • News & IR
      • NEWS
      • NETWORK
      • NOTICE & IR
  • Contact
Our Offering
Service
  • Dx HEALTH CHECK
  • CRO
  • CDx
  • CDO
  • CMO
  • CSO
  • KHUB CONSORTIUM
  • DTx
Product
  • Dx PRODUCT · PIPELINE
  • Vx PRODUCT · PIPELINE
  • CONSUMER HEALTH
  • Dx&Vx 2023 AWARD IMPACT
Back
Our Company
About Us
  • GOAL & PROMISE
  • ESG
  • LEADERSHIP
  • MICROBIOME HISTORY
  • COMPANY HISTORY
News & IR
  • NEWS
  • NETWORK
  • NOTICE & IR
Back
Contact
Corporate
Back

  • Home
  • News
2023-08-21 | views:263
올가을 코로나19 재확산하나...美, 전 국민 부스터샷 접종 촉구
2023-08-18 | views:331
디엑스앤브이엑스, 권규찬 '신약'·이용구 '영업' 체제로
2023-08-16 | views:334
식약처, 신속한 제품화 위한 '규제과학혁신법' 개정·공포
2023-08-16 | views:245
'삶의 질 개선' 중증 천식약 누칼라, RSA 급여 등재 '관심'
2023-08-14 | views:400
"2차전지 다음은" 바이오로 눈돌리는 투자자…ETF 출시도 '속속'
2023-08-14 | views:300
디엑스앤브이엑스, 2분기 매출 141억…전년比 98% 증가
2023-08-14 | views:77
흡입형 호흡기 치료제 시장, 심비코트ㆍ세레타이드 굳건
2023-08-09 | views:121
최근 3년 수익성 높은 글로벌 제약사, ‘특정 질병‧치료영역’ 집중했다
2023-08-08 | views:119
mRNA 보유국 된 일본…한국은 언제쯤?
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8.   
Service
  • Dx HEALTH CHECK
  • CRO
  • CDx
  • CDO
  • CMO
  • CSO
  • KHUB CONSORTIUM
  • DTx
Product
  • Dx PRODUCT · PIPELINES
  • Vx PRODUCT · PIPELINES
  • CONSUMER HEALTH
  • Dx&Vx 2023 Award Impact
About Us
  • GOAL & PROMISE
  • ESG
  • LEADERSHIP
  • MICROBIOME HISTORY
  • COMPANY HISTORY
News & IR
  • NEWS
  • NETWORK
  • NOTICE & IR
  • 서울시 금천구 디지털로 173, 10층 (가산동, 엘리시아)
  • 고객사 문의 : 02-890-8709
  • 주주 문의 : 02-6964-8770
  • Fax : 02-6964-8755
  • Tel : 02-890-8700
개인정보처리방침
© 2022 Dx&Vx. ALL RIGHTS RESERVED.
고객문의